YieldMax MRNA Option Income Strategy ETF Announces Dividend of $0.00 (NYSEARCA:MRNY)

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNYGet Free Report) announced a dividend on Monday, December 29th. Shareholders of record on Tuesday, December 30th will be given a dividend of 0.0002 per share on Wednesday, December 31st. This represents a yield of 6.0%. The ex-dividend date of this dividend is Tuesday, December 30th.

YieldMax MRNA Option Income Strategy ETF Stock Up 0.1%

MRNY stock opened at $15.45 on Tuesday. YieldMax MRNA Option Income Strategy ETF has a twelve month low of $13.60 and a twelve month high of $56.65. The business has a 50 day moving average of $15.59 and a 200 day moving average of $18.85.

YieldMax MRNA Option Income Strategy ETF Company Profile

(Get Free Report)

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.

See Also

Dividend History for YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY)

Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.